Total Payments
$81,181
2024 Payments
$75.78
Companies
11
Transactions
162
Medicare Patients
4,319
Medicare Billing
$195,295
Payment Breakdown by Category
Other$72,180 (88.9%)
Food & Beverage$4,059 (5.0%)
Travel$3,534 (4.4%)
Consulting$1,287 (1.6%)
Education$121.88 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $72,180 | 45 | 88.9% |
| Food and Beverage | $4,059 | 85 | 5.0% |
| Travel and Lodging | $3,534 | 19 | 4.4% |
| Consulting Fee | $1,287 | 5 | 1.6% |
| Education | $121.88 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $77,810 | 100 | $0 (2023) |
| Olympus Corporation of the Americas | $1,513 | 8 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $871.33 | 15 | $0 (2023) |
| Genentech USA, Inc. | $443.39 | 26 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $173.69 | 6 | $0 (2019) |
| GlaxoSmithKline, LLC. | $85.41 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $85.20 | 1 | $0 (2018) |
| Inspire Medical Systems, Inc. | $75.78 | 1 | $0 (2024) |
| Shire North American Group Inc | $64.96 | 1 | $0 (2018) |
| United Therapeutics Corporation | $36.56 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.78 | 1 | Inspire Medical Systems, Inc. ($75.78) |
| 2023 | $5,805 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,571) |
| 2022 | $5,866 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,729) |
| 2021 | $7,545 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,311) |
| 2020 | $111.76 | 3 | AstraZeneca Pharmaceuticals LP ($111.76) |
| 2019 | $18,215 | 37 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17,743) |
| 2018 | $18,020 | 41 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17,572) |
| 2017 | $25,545 | 47 | Boehringer Ingelheim Pharmaceuticals, Inc. ($23,884) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/04/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $75.78 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $141.48 | General |
| Category: RESPIRATORY | ||||||
| 10/20/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 06/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $71.72 | General |
| 06/27/2023 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $22.75 | General |
| Category: Respiratory | ||||||
| 03/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $75.81 | General |
| Category: RESPIRATORY | ||||||
| 03/23/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 03/02/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $85.41 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Education | In-kind items and services | $8.88 | General |
| Category: RESPIRATORY | ||||||
| 01/03/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| 12/08/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Respiratory | ||||||
| 12/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Education | In-kind items and services | $9.91 | General |
| 11/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,530.00 | General |
| 11/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $66.40 | General |
| 11/02/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Education | In-kind items and services | $9.91 | General |
| 09/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,530.00 | General |
| Category: RESPIRATORY | ||||||
| 09/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Respiratory | ||||||
| 07/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $77.59 | General |
| 06/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,530.00 | General |
| Category: RESPIRATORY | ||||||
| 05/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| 12/02/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $105.18 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,057 | 1,098 | $340,151 | $47,041 |
| 2022 | 16 | 916 | 935 | $170,410 | $40,729 |
| 2021 | 18 | 1,176 | 1,229 | $211,939 | $54,748 |
| 2020 | 18 | 1,170 | 1,278 | $209,673 | $52,776 |
Total Patients
4,319
Total Services
4,540
Medicare Billing
$195,295
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 149 | 169 | $16,956 | $10,993 | 64.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 63 | 67 | $37,506 | $5,786 | 15.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 56 | 56 | $10,732 | $4,954 | 46.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 53 | 53 | $27,734 | $4,480 | 16.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 35 | 40 | $6,136 | $3,902 | 63.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 26 | 26 | $6,682 | $3,060 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 46 | $4,416 | $2,780 | 62.9% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 86 | 86 | $12,104 | $2,711 | 22.4% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2023 | 54 | 54 | $4,644 | $1,585 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 39 | 39 | $2,535 | $1,557 | 61.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 15 | $4,395 | $1,465 | 33.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 130 | 132 | $94,908 | $1,066 | 1.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 18 | 19 | $5,985 | $951.02 | 15.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 133 | 134 | $48,240 | $809.08 | 1.7% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 134 | 136 | $38,302 | $756.97 | 2.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 26 | 26 | $18,876 | $184.80 | 1.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 156 | 168 | $20,195 | $10,946 | 54.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 37 | 37 | $9,723 | $4,681 | 48.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 45 | 45 | $18,076 | $4,292 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 79 | 79 | $6,005 | $3,619 | 60.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 30 | 30 | $11,060 | $2,619 | 23.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $7,618 | $2,383 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 27 | 27 | $5,358 | $2,109 | 39.4% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 51 | 52 | $5,468 | $1,717 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 18 | $1,728 | $1,313 | 76.0% |
About Dr. Andrew Dixon, MD
Dr. Andrew Dixon, MD is a Specialist/Technologist healthcare provider based in Bangor, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538129226.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Dixon, MD has received a total of $81,181 in payments from pharmaceutical and medical device companies, with $75.78 received in 2024. These payments were reported across 162 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($72,180).
As a Medicare-enrolled provider, Dixon has provided services to 4,319 Medicare beneficiaries, totaling 4,540 services with total Medicare billing of $195,295. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist/Technologist
- Other Specialties Pulmonary Disease
- Location Bangor, ME
- Active Since 03/25/2006
- Last Updated 03/10/2022
- Taxonomy Code 225500000X
- Entity Type Individual
- NPI Number 1538129226
Products in Payments
- OFEV (Drug) $14,689
- SPIRIVA RESPIMAT (Drug) $4,621
- EVIS EXERA (Device) $1,513
- FASENRA (Biological) $446.82
- Xolair (Biological) $347.39
- FASENRA (Drug) $167.07
- BREZTRI AEROSPHERE (Drug) $111.76
- Esbriet (Biological) $96.00
- NUCALA (Biological) $85.41
- XOLAIR (Biological) $85.20
- INSPIRE (Device) $75.78
- ARALAST (Biological) $64.96
- OPSUMIT MACITENTAN (Drug) $59.25
- BEVESPI AEROSPHERE (Drug) $35.87
- UPTRAVI (Drug) $23.67
- remede System (Device) $22.75
- TYVASO (Drug) $18.34
- ORENITRAM (Drug) $18.22
- OPSUMIT (Drug) $15.90
- TEZSPIRE (Biological) $11.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.